Published in Allergy Asthma Proc on February 14, 2013
Tim-3: an activation marker and activation limiter of innate immune cells. Front Immunol (2013) 1.05
Upregulation of Tim-3 on CD4(+) T cells is associated with Th1/Th2 imbalance in patients with allergic asthma. Int J Clin Exp Med (2015) 0.83
Histone acetyltransferease p300 modulates TIM4 expression in dendritic cells. Sci Rep (2016) 0.83
Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients. Clin Exp Med (2013) 0.81
Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus. Diagn Pathol (2015) 0.80
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage. J Immunol Res (2015) 0.79
Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model. Parasitol Res (2016) 0.78
Tim-3 and Tim-4 as the potential targets for antitumor therapy. Hum Vaccin Immunother (2015) 0.77
TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner. Br J Cancer (2015) 0.77
TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis. Oncotarget (2016) 0.77
Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia. Cancer Cell Int (2014) 0.76
TIM-4 is expressed on invariant NKT cells but dispensable for their development and function. Oncotarget (2016) 0.75
Immune Regulation and Antitumor Effect of TIM-1. J Immunol Res (2016) 0.75
Increased expression of T cell immunoglobulin and mucin domain 4 is positively associated with the disease severity of patients with ankylosing spondylitis. Inflammation (2015) 0.75
Effects of Tim-3 silencing on the viability of fibroblast-like synoviocytes and lipopolysaccharide-induced inflammatory reactions. Exp Ther Med (2017) 0.75
TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression. Int J Mol Med (2017) 0.75
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm. MBio (2017) 0.75
CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc Natl Acad Sci U S A (2011) 2.23
Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3' regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol (2008) 0.99
Role of nuclear factor-ĸB in breast and colorectal cancer. Curr Allergy Asthma Rep (2013) 0.98
Germline deletion of Igh 3' regulatory region elements hs 5, 6, 7 (hs5-7) affects B cell-specific regulation, rearrangement, and insulation of the Igh locus. J Immunol (2012) 0.97
Toxic epidermal necrolysis in systemic lupus erythematosus. Autoimmun Rev (2005) 0.95
Cutaneous inflammatory malignant fibrous histiocytoma presenting with a leukemoid reaction: a case report and review of the literature. Case Rep Med (2012) 0.93
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease. Autoimmun Rev (2013) 0.91
Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination. J Biol Chem (2011) 0.91
Dynamic changes in binding of immunoglobulin heavy chain 3' regulatory region to protein factors during class switching. J Biol Chem (2011) 0.89
Alzheimer's disease and immunotherapy. Aging Dis (2013) 0.86
Update on hidden food allergens and food labeling. Allergy Asthma Proc (2008) 0.85
Immune response to nanomaterials: implications for medicine and literature review. Curr Allergy Asthma Rep (2013) 0.84
NF-κB and systemic lupus erythematosus: examining the link. J Nephrol (2013) 0.82
Minimal difference in the prevalence of asthma in the urban and rural environment. Clin Med Insights Pediatr (2012) 0.81
Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract. Allergy Asthma Proc (2007) 0.81
Lupus nephritis: review of the literature. Curr Allergy Asthma Rep (2013) 0.81
Dermatophagoides extract-treated confluent type II epithelial cells (cA549) and human lung mesenchymal cell growth. Ann Allergy Asthma Immunol (2005) 0.80
Transforming growth factor beta: a role in the upper airway and rhinosinusitis-Dermatophagoides pteronyssinus-induced apoptosis with pulmonary alveolar cells. Am J Rhinol Allergy (2011) 0.80
Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells. Ann Allergy Asthma Immunol (2005) 0.79
Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review. Case Rep Hematol (2011) 0.79
Bacterial biofilms and chronic rhinosinusitis. Allergy Asthma Proc (2013) 0.79
Asthma in the geriatric population. Allergy Asthma Proc (2013) 0.78
Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review. ISRN Oncol (2012) 0.78
Should fracture risk influence our decision making in asthma care? Ann Allergy Asthma Immunol (2011) 0.76
Eosinophilic disorders in various diseases. Curr Allergy Asthma Rep (2012) 0.76
What every physician should know about rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays. Allergy Asthma Proc (2012) 0.75
Role of mucosal inflammation in eosinophilic esophagitis: review of the literature. ISRN Gastroenterol (2010) 0.75
Persistent dyspnea and leg edema. Allergy Asthma Proc (2007) 0.75
Cough, wheezing, and rash in a patient with a history of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol (2005) 0.75
Lymphadenopathy, productive cough, eosinophilia, and a new-onset acquired immunodeficiency syndrome. Allergy Asthma Proc (2011) 0.75
Rash, drug hypersensitivity, and autoimmunity in a 20-year-old woman. Ann Allergy Asthma Immunol (2005) 0.75